Begliarzade, Sema,
Sufianov, Albert,
Ilyasova, Tatiana,
Shumadalova, Alina,
Sufianov, Rinat,
Beylerli, Ozal,
Yan, Zhongrui (2024) into the complex interplay between circRNAs and CC, we are paving the way for innovative, individualized
approachesBeylerli, Ozal,
Shi, Huaizhang,
Begliarzade, Sema,
Shumadalova, Alina,
Ilyasova, Tatiana,
Sufianov, Albert (2024) and sensitivity of ncRNAs, potentially reshaping
approaches to tackle this challenge and elevate treatment
Gareev, Ilgiz,
Beylerli, Ozal,
Tamrazov, Rasim,
Ilyasova, Tatiana,
Shumadalova, Alina,
Du, Weijie,
Yang, Baofeng (2023) . These include the quest for and development of innovative methodological
approaches, as well as the enhancement
Lenkova, Ksenia,
Khusainova, Rita,
Minyazeva, Raushaniya,
Zaripova, Aliya,
Gilyazova, Irina,
Mokrysheva, Natalia,
Minniakhmetov, Ildar (2024) genetic screening in order to improve diagnostic and therapeutic
approaches for cervical cancer patients
matrices, to mitigate donor variability. These
approaches offer promising avenues for enhancing
Subbotin, Dmitrii,
Ionova, Sofya,
Marakhonov, Andrey,
Saifullina, Elena,
Borovikov, Artem,
Akhmadeeva, Leila,
Chausova, Polina,
Ryzhkova, Oksana,
Zinchenko, Rena,
Kutsev, Sergey,
Murtazina, Aysylu (2024) variants from historically isolated populations is important for molecular genetic diagnosis. This
approachTalybov, Rustam,
Beylerli, Ozal,
Mochalov, Vadim,
Prokopenko, Alexey,
Ilyasova, Tatiana,
Trofimova, Tatiana,
Sufianov, Albert,
Guang, Yang (2022) approach for this type of tumor. Nevertheless, PLCNS is characterized by an atypical manifestation, which
Vaiman, E.E.,
Shnayder, N.A.,
Zhuravlev, N.M.,
Petrova, M.M.,
Asadullin, A.R.,
Al-Zamil, M.,
Garganeeva, N.R.,
Shipulin, G.A.,
Cumming, G.,
Nasyrova, R.F. (2022) on AP-induced LQTS and proposes a
new personalized
approach to assessing the risk of its development